Some of the common side effects associated with GLP-1 treatments include: Gastrointestinal Issues: GLP-1 medications can sometimes cause nausea, vomiting, diarrhea, or constipation, especially during the initial stages of treatment
Patients should seek prompt medical guidance for severe or persistent vomiting, signs of dehydration, severe abdominal pain, fainting, symptoms of low blood sugar, inability to keep fluids down, worsening constipation with pain or bloating, or any symptom that feels unsafe
This data is essential for a provider to determine if you are a candidate for a GLP-1 program
Nature 578 , 444448 (2020)
Empagliflozin and risk of incident gout: analysis from the EMPagliflozin comparative effectiveness and safEty (EMPRISE) cohort study
1.10 Years leading Professional manufacturer